Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Ameriprise Financial Inc is an asset management business based in the US. Ameriprise Financial shares (AMP) are listed on the NYSE and all prices are listed in US Dollars. Ameriprise Financial employs 12,300 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$296.73|
|52-week range||$152.33 - $292.30|
|50-day moving average||$271.33|
|200-day moving average||$258.28|
|Wall St. target price||$311.56|
|Dividend yield||$4.25 (1.49%)|
|Earnings per share (TTM)||$8.66|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||3.81%|
|1 month (2021-09-21)||17.05%|
|3 months (2021-07-21)||18.16%|
|6 months (2021-04-21)||19.97%|
|1 year (2020-10-21)||77.95%|
|2 years (2019-10-21)||105.63%|
|3 years (2018-10-19)||118.41%|
|5 years (2016-10-21)||204.12%|
Valuing Ameriprise Financial stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ameriprise Financial's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ameriprise Financial's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Ameriprise Financial shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Ameriprise Financial's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.8854. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ameriprise Financial's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ameriprise Financial's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.2 billion.
The EBITDA is a measure of a Ameriprise Financial's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$13 billion|
|Operating margin TTM||15.3%|
|Gross profit TTM||$5.8 billion|
|Return on assets TTM||0.76%|
|Return on equity TTM||17.48%|
|Market capitalisation||$33 billion|
TTM: trailing 12 months
There are currently 2.1 million Ameriprise Financial shares held short by investors – that's known as Ameriprise Financial's "short interest". This figure is 2.2% down from 2.1 million last month.
There are a few different ways that this level of interest in shorting Ameriprise Financial shares can be evaluated.
Ameriprise Financial's "short interest ratio" (SIR) is the quantity of Ameriprise Financial shares currently shorted divided by the average quantity of Ameriprise Financial shares traded daily (recently around 474833.25740319). Ameriprise Financial's SIR currently stands at 4.39. In other words for every 100,000 Ameriprise Financial shares traded daily on the market, roughly 4390 shares are currently held short.
However Ameriprise Financial's short interest can also be evaluated against the total number of Ameriprise Financial shares, or, against the total number of tradable Ameriprise Financial shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ameriprise Financial's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Ameriprise Financial shares in existence, roughly 20 shares are currently held short) or 0.0184% of the tradable shares (for every 100,000 tradable Ameriprise Financial shares, roughly 18 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ameriprise Financial.
Find out more about how you can short Ameriprise Financial stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Ameriprise Financial.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 30.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Ameriprise Financial's overall score of 30.8 (as at 12/31/2018) is nothing to write home about – landing it in it in the 48th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Ameriprise Financial is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 9.8/100
Ameriprise Financial's environmental score of 9.8 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Ameriprise Financial is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 16.66/100
Ameriprise Financial's social score of 16.66 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Ameriprise Financial is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 19.84/100
Ameriprise Financial's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Ameriprise Financial is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Ameriprise Financial scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Ameriprise Financial has, for the most part, managed to keep its nose clean.
|Total ESG score||30.8|
|Total ESG percentile||48.36|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
|Level of controversy||2|
Dividend payout ratio: 25.99% of net profits
Recently Ameriprise Financial has paid out, on average, around 25.99% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.56% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Ameriprise Financial shareholders could enjoy a 1.56% return on their shares, in the form of dividend payments. In Ameriprise Financial's case, that would currently equate to about $4.25 per share.
While Ameriprise Financial's payout ratio might seem fairly standard, it's worth remembering that Ameriprise Financial may be investing much of the rest of its net profits in future growth.
Ameriprise Financial's most recent dividend payout was on 19 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 5 August 2021 (the "ex-dividend date").
Over the last 12 months, Ameriprise Financial's shares have ranged in value from as little as $152.3286 up to $292.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ameriprise Financial's is 1.6571. This would suggest that Ameriprise Financial's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ameriprise Financial, Inc. , through its subsidiaries, provides various financial products and services to individual and institutional clients in the United States and internationally. It operates through four segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The Advice & Wealth Management segment provides financial planning and advice; brokerage products and services for retail and institutional clients; discretionary and non-discretionary investment advisory accounts; mutual funds; insurance and annuities products; cash management and banking products; and face-amount certificates. The Asset Management segment offers investment management and advice, and investment products to retail, high net worth, and institutional clients through unaffiliated third-party financial institutions and institutional sales force. This segment products also include U. S.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.